Insulin aspart, recombinant Subcutaneous and Pramipexole Dihydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pramipexole Dihydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pramipexole
Brand name: Mirapex, Mirapex ER
Synonyms: Pramipexole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pramipexole ER Tablets
- Insulin aspart, recombinant Subcutaneous-Pramipexole Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Pramipexole Tablets
- Insulin aspart, recombinant Subcutaneous-Pramlintide
- Insulin aspart, recombinant Subcutaneous-Pramlintide Acetate
- Insulin aspart, recombinant Subcutaneous-Pramlintide Subcutaneous
- Pramipexole Dihydrochloride-Insulin degludec
- Pramipexole Dihydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Pramipexole Dihydrochloride-Insulin Degludec (U-100) Vials
- Pramipexole Dihydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Pramipexole Dihydrochloride-Insulin degludec and liraglutide
- Pramipexole Dihydrochloride-Insulin degludec and liraglutide Subcutaneous